Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

Jan 7, 2026 08:34AM FibroBiologics CEO outlines 2025 progress in shareholder letter

Jan 5, 2026 08:32AM FibroBiologics reports positive preclinical results for disc therapy

Jan 2, 2026 06:36AM H.C. Wainwright Reiterates Buy Rating on FibroBiologics (FBLG)

Dec 23, 2025 04:04PM FibroBiologics (FBLG) files for 22.94M share offering by selling stockholders

Nov 26, 2025 08:31AM FibroBiologics pays off convertible debt to strengthen balance sheet

Nov 5, 2025 06:07AM FibroBiologics (FBLG) PT Lowered to $5 at H.C. Wainwright

Sep 26, 2025 09:00AM BioVie and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Sep 12, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on FibroBiologics (FBLG)

Sep 11, 2025 08:32AM FibroBiologics reports positive psoriasis treatment study results

Sep 10, 2025 08:30AM FibroBiologics reports progress in bone marrow organoid development

Aug 5, 2025 06:43AM FibroBiologics (FBLG) PT Lowered to $10 at H.C. Wainwright

Jul 28, 2025 08:31AM FibroBiologics files patent for multipotent cell generation methods

Jul 11, 2025 09:00AM Brag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jul 3, 2025 09:00AM Fathom Holdings and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jun 9, 2025 08:31AM FibroBiologics (FBLG) names Jason Davis as CFO

Apr 8, 2025 08:35AM FibroBiologics (FBLG) opens new Houston lab space

Mar 4, 2025 08:30AM FibroBiologics (FBLG) Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

Dec 30, 2024 08:32AM FibroBiologics (FBLG) Files for 41.29M Share Offering by Selling Stockhodlers

Dec 23, 2024 07:55AM FibroBiologics (FBLG) Announces $25M Financing

Dec 11, 2024 04:08PM Rodman & Renshaw Starts FibroBiologics (FBLG) at Buy

Nov 19, 2024 09:15AM FibroBiologics (FBLG) Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

Nov 14, 2024 09:16AM FibroBiologics (FBLG) Files Patent Application Covering Reduction of Blood Clots Associated with IBMIR in Cell-Based Therapeutics

Nov 14, 2024 09:15AM FibroBiologics (FBLG) Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

Oct 30, 2024 07:55AM H.C. Wainwright Starts FibroBiologics (FBLG) at Buy

Oct 29, 2024 09:16AM FibroBiologics (FBLG) Announces Updates for Novel Artificial Thymus Organoid Technology

Oct 18, 2024 08:31AM FibroBiologics (FBLG) and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

Oct 16, 2024 09:15AM FibroBiologics (FBLG) Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the EU Patent Office

Sep 4, 2024 07:09AM EF Hutton Starts FibroBiologics (FBLG) at Buy

Aug 20, 2024 09:31AM FibroBiologics (FBLG) Files Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

Jun 25, 2024 09:31AM FibroBiologics (FBLG) Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

Jun 18, 2024 04:14PM FibroBiologics (FBLG) Announces 16.02M Share Offering by Selling Stockholders